Search research articles
Contact Us
Filters
Showing results (1-10 of 76) with videos related to
Page
of 8
Sort By:
Current Opinion in Nephrology and Hypertension
|
November 18, 2015
Aldosterone in vascular and metabolic dysfunction
James M Luther
Steroids
|
September 8, 2014
Effects of aldosterone on insulin sensitivity and secretion
James M Luther
Current Opinion in Nephrology and Hypertension
|
July 4, 2014
Is there a new dawn for selective mineralocorticoid receptor antagonism?
James M Luther
Journal of the American Society of Nephrology : JASN
|
December 17, 2011
Sodium intake, ACE inhibition, and progression to ESRD
James M Luther
Hypertension (Dallas, Tex. : 1979)
|
September 20, 2023
Unilaterally Successful Adrenal Vein Sampling: Use or Repeat?
James M Luther, Adina F Turcu
Kidney International Supplements
|
May 9, 2022
The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis
James M Luther, Agnes B Fogo
Hypertension (Dallas, Tex. : 1979)
|
August 14, 2025
Approaching Drug Choices and Challenges for the Management of Hypertension
Adam P Bress, James M Luther
Prostaglandins & Other Lipid Mediators
|
July 25, 2016
Epoxyeicosatrienoic acids and glucose homeostasis in mice and men
James M Luther, Nancy J Brown
Advances in Kidney Disease and Health
|
July 3, 2026
New Drugs on the Horizon for Hypertension
Geonte G Jackson, James M Luther, Matthew R Alexander
Kidney International
|
April 2, 2009
'Labile hypertension' can be due to autonomic nervous system failure
Satish R Raj, James M Luther, Kyoko Sato, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 76) with videos related to
Sort By:
Page
of 8
Current Opinion in Nephrology and Hypertension
|
November 18, 2015
Aldosterone in vascular and metabolic dysfunction
James M Luther
Steroids
|
September 8, 2014
Effects of aldosterone on insulin sensitivity and secretion
James M Luther
Current Opinion in Nephrology and Hypertension
|
July 4, 2014
Is there a new dawn for selective mineralocorticoid receptor antagonism?
James M Luther
Journal of the American Society of Nephrology : JASN
|
December 17, 2011
Sodium intake, ACE inhibition, and progression to ESRD
James M Luther
Hypertension (Dallas, Tex. : 1979)
|
September 20, 2023
Unilaterally Successful Adrenal Vein Sampling: Use or Repeat?
James M Luther, Adina F Turcu
Kidney International Supplements
|
May 9, 2022
The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis
James M Luther, Agnes B Fogo
Hypertension (Dallas, Tex. : 1979)
|
August 14, 2025
Approaching Drug Choices and Challenges for the Management of Hypertension
Adam P Bress, James M Luther
Prostaglandins & Other Lipid Mediators
|
July 25, 2016
Epoxyeicosatrienoic acids and glucose homeostasis in mice and men
James M Luther, Nancy J Brown
Advances in Kidney Disease and Health
|
July 3, 2026
New Drugs on the Horizon for Hypertension
Geonte G Jackson, James M Luther, Matthew R Alexander
Kidney International
|
April 2, 2009
'Labile hypertension' can be due to autonomic nervous system failure
Satish R Raj, James M Luther, Kyoko Sato, et al.
Page
of 8